1. Home
  2. BOLT vs PMEC Comparison

BOLT vs PMEC Comparison

Compare BOLT & PMEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • PMEC
  • Stock Information
  • Founded
  • BOLT 2015
  • PMEC 1984
  • Country
  • BOLT United States
  • PMEC Singapore
  • Employees
  • BOLT N/A
  • PMEC N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • PMEC
  • Sector
  • BOLT Health Care
  • PMEC
  • Exchange
  • BOLT Nasdaq
  • PMEC Nasdaq
  • Market Cap
  • BOLT 25.3M
  • PMEC 26.1M
  • IPO Year
  • BOLT 2021
  • PMEC 2023
  • Fundamental
  • Price
  • BOLT $0.52
  • PMEC $0.75
  • Analyst Decision
  • BOLT Hold
  • PMEC
  • Analyst Count
  • BOLT 5
  • PMEC 0
  • Target Price
  • BOLT $1.25
  • PMEC N/A
  • AVG Volume (30 Days)
  • BOLT 168.8K
  • PMEC 71.5K
  • Earning Date
  • BOLT 11-12-2024
  • PMEC 12-31-2024
  • Dividend Yield
  • BOLT N/A
  • PMEC N/A
  • EPS Growth
  • BOLT N/A
  • PMEC N/A
  • EPS
  • BOLT N/A
  • PMEC N/A
  • Revenue
  • BOLT $9,779,000.00
  • PMEC $72,524,000.00
  • Revenue This Year
  • BOLT $9.87
  • PMEC N/A
  • Revenue Next Year
  • BOLT N/A
  • PMEC N/A
  • P/E Ratio
  • BOLT N/A
  • PMEC N/A
  • Revenue Growth
  • BOLT 35.86
  • PMEC 5.07
  • 52 Week Low
  • BOLT $0.50
  • PMEC $0.49
  • 52 Week High
  • BOLT $1.56
  • PMEC $4.15
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 38.20
  • PMEC 50.76
  • Support Level
  • BOLT $0.50
  • PMEC $0.65
  • Resistance Level
  • BOLT $0.59
  • PMEC $0.79
  • Average True Range (ATR)
  • BOLT 0.03
  • PMEC 0.07
  • MACD
  • BOLT -0.00
  • PMEC -0.01
  • Stochastic Oscillator
  • BOLT 24.49
  • PMEC 43.78

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About PMEC Primech Holdings Ltd.

Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.

Share on Social Networks: